Search the Newsreel

Fortinet (FTNT) awards 1,836 RSUs to director Ming Hsieh with 2026–27 vesting

Fortinet (FTNT) director Ming Hsieh was granted 1,836 Restricted Stock Units (RSUs) that will vest in equal increments between September 2026 and June 2027, subject to his continued service. This transaction, reported via a Form 4 filing, is a compensation-related award rather than a …

Fortinet (FTNT) awards 1,836 RSUs to board member Derek T. Kan

Fortinet, Inc. announced that director Derek T. Kan was granted 1,836 Restricted Stock Units (RSUs). These RSUs will vest in equal increments on specific dates from September 2026 to June 2027, contingent on his continued service to the company. Following this transaction, Kan directly …

Crinetics Pharmaceuticals (CRNX): Wellington reports 7.13M-share, 6.76% ownership

Wellington Management entities have reported beneficial ownership of 7,131,084 shares, or 6.76%, of Crinetics Pharmaceuticals (CRNX) common stock. The filing indicates shared voting power over 6,310,651 shares and shared dispositive power over all 7,131,084 shares, with economic interests belonging to advisory clients. No single …

Kinetik Holdings (KNTK) director reports 2,739-share stock sale at $51.51

Kinetik Holdings Inc. director Deborah L. Byers reported selling 2,739 shares of Class A Common Stock on August 12, 2026, at a weighted average price of $51.51 per share. Following this transaction, she directly holds 24,389 shares of Class A Common Stock. The sale …

Wellington group discloses over 5% Cytokinetics (CYTK) holding for clients

Wellington Management Group LLP and related entities have disclosed a 5.12% beneficial ownership stake in Cytokinetics, Incorporated (CYTK) for their clients, as detailed in an Amendment No. 2 to a Schedule 13G filing. This holding, totaling 7,116,724 shares, is managed by various Wellington investment …

CYTK Maintained by Barclays -- Price Target Raised to $110

Barclays has maintained an Overweight rating for Cytokinetics (CYTK) and increased its price target to $110, reflecting a positive outlook despite the company being unprofitable. The stock is considered undervalued by 60.9% according to GF Value™, but its GF Score™ of 51/100 indicates average …

Why Fabrinet (FN) Shares Climbed After Its Latest Update

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Fabrinet (FN) drew fresh attention after announcing that its management will speak at the Rosenblatt 6th Annual Age of AI Technology Summit on …

Why Pinetree Capital Ltd stock is rising today

Kinetic Development Deepens Stake in MC Mining With US$16 Million Share Subscription and Bridge Loan

Cytokinetics files lawsuit seeking patent judgment against Bristol-Myers Squibb

Cytokinetics has filed a lawsuit against Bristol-Myers Squibb and MyoKardia, seeking a declaratory judgment that it does not infringe on U.S. Patent No. 12,616,697 and that the patent's claims are invalid. The company also seeks an injunction to prevent infringement litigation related to its …

Form 8K Cytokinetics Inc For: 13 August By Investing.com

This article from Investing.com reports that Cytokinetics Inc. filed a Form 8K on August 13th. The Form 8K is a crucial document that companies file with the SEC to announce major events that shareholders should know about. No specific details about the content of …

REINET INVESTMENTS SCA – Reinet annual general meeting and extraordinary general meeting of shareholders approves full agenda

Barclays raises Cytokinetics stock price target on strong Myqorzo sales

Barclays has increased its price target for Cytokinetics (NASDAQ: CYTK) shares to $110 from $95, maintaining an Overweight rating. This upgrade follows strong second-quarter Myqorzo sales of $25.3 million, significantly beating consensus estimates. The drug's successful launch and prescription growth, alongside the company's better-than-expected …

Fabrinet (FN) Heads To Rosenblatt AI Summit As Fair Value Debate Builds

Fabrinet (FN) is set to participate in the Rosenblatt 6th Annual Age of AI Technology Summit, which comes after a significant rebound in its share price. Despite a strong long-term performance, the stock's current valuation at around US$571.88 sparks debate, as its fair value …

ISQ Global Fund II GP LLC sells $16m in Kinetik Holdings (KNTK) stock

ISQ Global Fund II GP LLC, a significant owner and director of Kinetik Holdings Inc. (NASDAQ:KNTK), sold approximately $16.03 million worth of Class A Common Stock through several transactions between August 10 and August 12, 2026. These sales occurred while the stock was trading …

Kinetiko Energy Insiders AU$883k Short Of Breakeven On Stock Purchase

Fabrinet (FN) Stock Looks Stretched After A Very Strong Five Year Run

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Fabrinet stock has delivered a very strong run over the last few years, yet the valuation checks now lean expensive, which raises questions …

Kinetik Holdings (KNTK) holder to sell 84,701 Class A shares worth $4.34M

ISQ Global Fund II GP LLC plans to sell 84,701 Class A common shares of Kinetik Holdings Inc. (KNTK), valued at approximately $4.34 million, through Goldman Sachs & Co. LLC. The sale is expected to occur on or after August 12, 2026, and these …

Kinetik Holdings (KNTK) affiliates sell 310,691 Class A shares in open market

Affiliates of Kinetik Holdings Inc. (KNTK), including Buzzard Midstream LLC and entities associated with I Squared Capital, sold a total of 310,691 Class A Common Stock shares in open market transactions between August 10 and August 12, 2026. The sales occurred at weighted-average prices …

Fortinet Lifts 2026 Guidance on Firewall, SASE Demand: Buy the Stock?

Fortinet, Inc. FTNT has given investors fresh reason to pay attention after raising its full-year 2026 guidance on the back of accelerating firewall refresh cycles and surging SASE adoption. The upgraded outlook, delivered alongside second-quarter results, points to durable, broad-based demand across the company's …

Kinetik Holdings (KNTK) After Strong Results Looks Close To Fair Value

Fortinet flaws linked to major ransomware campaign

CISA, along with the FBI, has issued a warning about two Fortinet VPN vulnerabilities (CVE-2024-55591 and CVE-2025-24472) being actively exploited by the Gunra ransomware group. These flaws allow attackers to bypass multifactor authentication, steal data, and lock systems by creating malicious superuser accounts. Organizations …

Cómo están reaccionando los inversores ante el aumento de las previsiones de ingresos para 2026 de Fortinet (FTNT) tras los sólidos resultados del segundo trimestre

How Investors Are Reacting To Fortinet (FTNT) Raising 2026 Revenue Guidance After Strong Q2 Results

Fortinet (FTNT) reported strong Q2 2026 results with increased revenue and net income, leading the company to raise its full-year 2026 revenue guidance to US$8.02 billion to US$8.18 billion, reflecting 19% year-over-year growth. This upgraded outlook reinforces the company's shift towards recurring cybersecurity revenue, …

Wasatch Advisors LP Has $136.52 Million Stock Position in Fabrinet $FN

Wasatch Advisors LP significantly reduced its stake in Fabrinet (NYSE:FN) by 65.5% in the second quarter, selling 460,251 shares but still retaining 242,889 shares valued at $136.52 million. Despite this reduction, institutional investors collectively own 97.38% of Fabrinet. Analyst sentiment for Fabrinet remains "Moderate …

Handelsbanken Fonder AB Grows Stock Holdings in Cytokinetics, Incorporated $CYTK

Handelsbanken Fonder AB increased its stake in Cytokinetics, Incorporated by 63.8% in the second quarter, now owning 405,000 shares worth $34.5 million. This comes as other institutional investors have also adjusted their positions in the biopharmaceutical company. Analysts have largely maintained a "Moderate Buy" …

Cytokinetics Inc (CYTK) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Cytokinetics Inc (CYTK), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 22 analysts, the stock has a strong buy recommendation with an average target price of $79.00 and an upside space …

Kinetic Development Sets Board Meeting to Review Interim Results and Dividend

Dimensional Fund Advisors LP Has $6.23 Million Stock Holdings in Cytokinetics, Incorporated $CYTK

Dimensional Fund Advisors LP significantly increased its stake in Cytokinetics, Incorporated, acquiring an additional 75.2% of shares, totaling 94,503 shares valued at $6.23 million. Other institutional investors also raised their positions, reflecting broadly positive sentiment despite recent insider selling and a year-over-year revenue decline. …

TriNet Group (TNET) Edges Higher as Shares Hold Above Key Support - Pre-Earnings Momentum

Fortinet, Inc. (NASDAQ:FTNT) Receives Consensus Rating of "Hold" from Analysts

Fortinet, Inc. (NASDAQ:FTNT) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $150.91. The company recently exceeded quarterly earnings expectations, reporting an adjusted EPS of $0.90 and revenue of $2.05 billion. Despite the positive earnings, insiders have been …

Earnings Preview: Fabrinet to Report Financial Results Post-market on August 17

Fabrinet (FN) is scheduled to release its financial results after the market closes on August 17. The company is expected to report earnings of $1.81 per share, which would be a year-over-year increase of 10.37%. Investors will be watching for details on revenue performance …

Massive Update for Fortinet Stock Investors

Fortinet stock is experiencing a significant surge in 2026. The Motley Fool's Stock Advisor team has identified 10 top stock picks, though Fortinet was not among them, emphasizing their strong historical returns for subscribers. This article also highlights a "Total Conviction" signal, reminiscent of …

Kinetik Holdings (KNTK) holder plans 147,516-share NYSE sale under Form 144

ISQ Global Fund II GP LLC has filed a Form 144 to sell 147,516 shares of Kinetik Holdings Inc. (KNTK) Class A Common Stock on the NYSE through Goldman Sachs & Co. LLC. The aggregate market value of this planned sale is approximately $7.54 …

Goldman Sachs Asset Management (KNTK) reports 4.7% beneficial stake in Kinetik

Goldman Sachs Asset Management, L.P. has reported a 4.7% beneficial ownership stake in Kinetik Holdings Inc. Class A common stock through a SCHEDULE 13G/A filing. The firm beneficially owns 3,490,511.47 shares, with shared voting power over 3,457,629.47 shares and shared dispositive power over all …

Fabrinet schedules Aug. 18 fireside chat at AI summit

Fabrinet (FN) announced its management will participate in the Rosenblatt 6th Annual Age of AI Technology Summit, hosting a fireside chat on Tuesday, August 18, 2026, at 1:00 p.m. EDT. The event will be available via live and replay webcasts on the company's investor …